Skip to Main Content

Paper Details

Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trial.
Front Med (Lausanne)
6
2022
Author NameAffiliation
Gernot MarxUniversitatsklinikum Aachen
Pierre-Fran??ois LaterreCliniques Universitaires Saint-Luc (UCL Bruxelles)
Alexandre Mebazaa
Alexandre MebazaaUniversite de Paris, U Inserm, Federation Hospitalo-Universitaire PROMICE, Hopitaux Universitaires Saint-Louis-Lariboisiere
Peter PickkersDepartment of Intensive Care Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center
  • 1 - 5

Datasets

Release 1.2